Di Paolo, Julie A.,Jones, Randall Mark,Tumas, Daniel B.
申请号：
AU2016215643
公开号：
AU2016215643A1
申请日:
2016.01.29
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, including hematological malignancies. In particular, the methods include administration entospletinib and a Bcl-2 inhibitor, such as venetoclax, navitoclax, and ABT-737.
